| __timestamp | AbbVie Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 4279200 |
| Thursday, January 1, 2015 | 4285000000 | 6776987 |
| Friday, January 1, 2016 | 4366000000 | 21199860 |
| Sunday, January 1, 2017 | 4982000000 | 19957616 |
| Monday, January 1, 2018 | 10329000000 | 23495055 |
| Tuesday, January 1, 2019 | 6407000000 | 53647067 |
| Wednesday, January 1, 2020 | 6557000000 | 70244579 |
| Friday, January 1, 2021 | 7084000000 | 58060725 |
| Saturday, January 1, 2022 | 6510000000 | 57947447 |
| Sunday, January 1, 2023 | 8453000000 | 97944000 |
| Monday, January 1, 2024 | 12791000000 | 187077000 |
In pursuit of knowledge
In the dynamic world of pharmaceuticals, research and development (R&D) expenses are a key indicator of a company's commitment to innovation. Over the past decade, AbbVie Inc. and Axsome Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, AbbVie consistently allocated substantial resources to R&D, with expenses peaking in 2018 at over 10 billion dollars. This represents a staggering 200% increase from their 2014 expenditure. In contrast, Axsome Therapeutics, a smaller player, showed a more modest yet significant growth in R&D spending, culminating in a 2023 figure that is over 20 times their 2014 investment.
These trends highlight the differing scales and strategies of these companies, with AbbVie leveraging its vast resources to maintain a competitive edge, while Axsome focuses on targeted innovation to carve its niche in the industry.
AbbVie Inc. or Bristol-Myers Squibb Company: Who Invests More in Innovation?
Research and Development Expenses Breakdown: AbbVie Inc. vs Biogen Inc.
Analyzing R&D Budgets: AbbVie Inc. vs CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
R&D Insights: How BeiGene, Ltd. and Axsome Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Exelixis, Inc. vs Axsome Therapeutics, Inc.
R&D Insights: How Axsome Therapeutics, Inc. and Veracyte, Inc. Allocate Funds
Comparing Innovation Spending: Axsome Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Dynavax Technologies Corporation
Research and Development Investment: Axsome Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Axsome Therapeutics, Inc. and Evotec SE